Hercules Capital (HTGC) has agreed to provide NorthStar Medical Technologies with a multi-year growth capital facility of up to $185 million, including a $100 million upfront financing, NorthStar said Tuesday.

NorthStar plans to use the funds for growth and expansion, particularly to invest in isotope production and clinical and commercial drug manufacturing capabilities, among others, the company said.